A number of research firms have changed their ratings and price targets for Inovio Pharmaceuticals (NASDAQ: INO): 10/26/2016 – Inovio Pharmaceuticals had its “overweight” rating reaffirmed by analysts at Piper Jaffray Cos.. They now have a $13.00 price target on the stock, down previously from $31.00. 10/26/2016 – Inovio Pharmaceuticals had its “buy” rating reaffirmed […]